april 26, 2004----jesup and lamont retained by commonwealth biotechnologies. They were seeking equity capitol to upgrade and equip their accredited biosafety level 3 laboratory suite.
May 28, 2004-----Commonwealth Biotechnologies, Inc. Closes $2.5M Private Placement. Jesup & Lamont Securities, Corp. acted as exclusive placement agent for the transaction.
This is just a hypothesis....but is this what is down the road for cygx in a few months? CYGX wants to build a new facility and that takes serious funding. Does Jesup and Lamont have deep pockets interested in biotech research and that is why cygx has retained them....or am I drawing to many paralells???
Comments appreciated It would certainly help them avoid some dilution.....